Endologix Comments on Alleged Patent Infringement

Endologix Comments on Alleged Patent Infringement

[at noodls] – IRVINE, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has become aware that Lifeport … more

View todays social media effects on ELGX

View the latest stocks trending across Twitter. Click to view dashboard

See who Endologix is hiring next, click here to view

Share this post